bone grafts bone graft substitutes and biologics
April Schultz
—
like BMPs Risk of adverse reactions (e.g., inflammatory responses) Potential for graft resorption or failure Regulatory issues surrounding biologic agents Variability in clinical outcomes depending on patient fact
